Hamid Dolatshad Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine University of Oxford Biography Publications Institution JoVE Articles Hamid Dolatshad has not added a biography. If you are Hamid Dolatshad and would like to personalize this page please email our Author Liaison for assistance. Publications The U2AF1S34F Mutation Induces Lineage-specific Splicing Alterations in Myelodysplastic Syndromes The Journal of Clinical Investigation. Jun, 2017 | Pubmed ID: 28436936 Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes Current Pharmaceutical Design. 2016 | Pubmed ID: 26916023 Application of Genome Editing Technologies to the Study and Treatment of Hematological Disease Advances in Biological Regulation. Jan, 2016 | Pubmed ID: 26433620 ASXL1 Mutation Correction by CRISPR/Cas9 Restores Gene Function in Leukemia Cells and Increases Survival in Mouse Xenografts Oncotarget. Dec, 2015 | Pubmed ID: 26623729 A Versatile Transgenic Allele for Mouse Overexpression Studies Mammalian Genome : Official Journal of the International Mammalian Genome Society. Dec, 2015 | Pubmed ID: 26369329 Application of CRISPR/Cas9 Genome Editing to the Study and Treatment of Disease Archives of Toxicology. Jul, 2015 | Pubmed ID: 25827103 Combining Gene Mutation with Gene Expression Data Improves Outcome Prediction in Myelodysplastic Syndromes Nature Communications. Jan, 2015 | Pubmed ID: 25574665 The Role of Splicing Factor Mutations in the Pathogenesis of the Myelodysplastic Syndromes Advances in Biological Regulation. Jan, 2014 | Pubmed ID: 24080589 Generazione di cellule Knock-out NK umano primario ed espansa utilizzando Cas9 ribonucleoproteine Meisam Naeimi Kararoudi1, Hamid Dolatshad2, Prashant Trikha1, Syed-Rehan A. Hussain3, Ezgi Elmas1, Jennifer A. Foltz1, Jena E. Moseman1, Aarohi Thakkar1, Robin J. Nakkula1, Margaret Lamb1, Nitin Chakravarti1, K. John McLaughlin3, Dean A. Lee1 1Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, 2Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, 3Center for Clinical and Translational Research, Nationwide Children's Hospital Research Institute JoVE 58237 Immunology and Infection
Generazione di cellule Knock-out NK umano primario ed espansa utilizzando Cas9 ribonucleoproteine Meisam Naeimi Kararoudi1, Hamid Dolatshad2, Prashant Trikha1, Syed-Rehan A. Hussain3, Ezgi Elmas1, Jennifer A. Foltz1, Jena E. Moseman1, Aarohi Thakkar1, Robin J. Nakkula1, Margaret Lamb1, Nitin Chakravarti1, K. John McLaughlin3, Dean A. Lee1 1Center for Childhood Cancer and Blood Disease, Nationwide Children's Hospital, 2Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, 3Center for Clinical and Translational Research, Nationwide Children's Hospital Research Institute JoVE 58237 Immunology and Infection